SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (3442)2/13/2022 2:34:52 PM
From: CuttingEdge Bio  Read Replies (1) | Respond to of 3557
 
Not really. The VEGF arm of the bispecific is at a higher molar dose than Lucentis is at its dosage. There is no way to know Ang2 is doing anything here. This was exactly how Novartis made Beovu look good